Profil
Gianna Hoffman-Luca is currently Director at Avalyn Pharma, Inc. since 2023, Senior Principal at Perceptive Advisors (Private Equity) since 2019, and Principal at Xontogeny LLC.
Formerly, Dr. Hoffman-Luca was Director at Cargo Therapeutics, Inc.
Postes actifs de Gianna Hoffman-Luca
| Sociétés | Poste | Début |
|---|---|---|
Xontogeny LLC
Xontogeny LLC Pharmaceuticals: MajorHealth Technology Operates biotech aggregator company | Corporate Officer/Principal | - |
Perceptive Advisors (Private Equity)
Perceptive Advisors (Private Equity) Investment ManagersFinance Perceptive Advisors invests in public and private middle market companies located across the globe. The firm focuses across a broad range of sectors and industries. It provides financing in the form of equity and debt for seed, early, later stage and growth transactions with an investment size of USD 10 – 300 million. The firm acts as lead and co-lead investor. It also takes a seat on a board of directors. | Private Equity Investor | - |
Anciens postes connus de Gianna Hoffman-Luca
| Sociétés | Poste | Fin |
|---|---|---|
| AVALYN PHARMA INC. | Directeur/Membre du Conseil | 01/04/2026 |
| CARO THERPAR | Directeur/Membre du Conseil | 01/10/2023 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Avalyn Pharma Inc.
Avalyn Pharma Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops inhaled therapies to treat rare respiratory & interstitial lung diseases | Health Technology |
Perceptive Advisors (Private Equity)
Perceptive Advisors (Private Equity) Investment ManagersFinance Perceptive Advisors invests in public and private middle market companies located across the globe. The firm focuses across a broad range of sectors and industries. It provides financing in the form of equity and debt for seed, early, later stage and growth transactions with an investment size of USD 10 – 300 million. The firm acts as lead and co-lead investor. It also takes a seat on a board of directors. | Finance |
Xontogeny LLC
Xontogeny LLC Pharmaceuticals: MajorHealth Technology Operates biotech aggregator company | Health Technology |
Cargo Therapeutics, Inc.
Cargo Therapeutics, Inc. BiotechnologyHealth Technology Engages in generation of adoptive cell therapies for cancer treatment | Health Technology |
















